BPG is committed to discovery and dissemination of knowledge
Case Report
Copyright: ©Author(s) 2026.
World J Clin Cases. Aug 16, 2026; 14(23): 121781
Published online Aug 16, 2026. doi: 10.12998/wjcc.121781
Table 4 Electroconvulsive therapy in Parkinson’s disease: Reviews and meta-analysis
Acute ECT
Ref.
Study type
Key findings
Faber and Trimble[53], 1991Narrative review of 27 studies, mostly case reports and uncontrolled studies with small samples; only one randomised-controlled trial; 20 studies included patients with comorbid depressionApproximately 50% of patients receiving ECT, irrespective of the presence or absence of psychiatric comorbidity, showed improvement in parkinsonian symptoms
Kennedy et al[54], 2003Systematic review of 51 studies evaluating ECT in movement disorderSignificant improvement in both psychiatric and motor symptoms of Parkinson’s disease with ECT; however, significant side effects, particularly delirium (44%-85%), were reported
Borisovskaya et al[55], 2016Systematic review of 43 studies of ECT in Parkinson’s disease with comorbid depressionDepression improved in 93% of patients; motor symptoms improved in 83%; up to 56% developed delirium, but no long-term cognitive impairment was observed in 94% of patients
Takamiya et al[56], 2021Meta-analysis of 14 studies (including 1 randomised-controlled trial1) evaluating ECT in PDECT significantly improved motor manifestations of Parkinson’s disease; improvement was significant in patients without psychiatric symptoms; ECT also significantly improved depression and psychosis, relieved the wearing-off phenomenon, and did not worsen cognitive functioning
Maintenance ECT
Kramer et al[57], 1999Major depressive disorder (n = 24)Major depressive disorder with PD (n = 10)
Much improved 75%Much improved 50%
Partially improved 12.5%Partially improved 40%


Write to the Help Desk